Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Gallenwege » Neoplasie 02. April 2026
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Cholezystitis - Cholelithiasis
Neoplasie
Anderes
Leber
Magen-Darm
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 862  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 17228  
   
Clonorchis sinensis and cholangiocarcinoma: molecular mechanisms and biomarker advances.
Parasite
Huang C, Wu Y, Wu A, Huang L, Fang S, Xu C, Liu T, Li Y, Li X.
PMID: 41919759 [PubMed - indexed for MEDLINE]


Targeted Therapy in Hepatobiliary Pancreatic Cancer (HPC): Advantages and Advancements of Antibody Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs.
Int J Mol Sci
Deb Nath T, Mukherjee A, Chauhan SC, Bandyopadhyay D.
PMID: 41898574 [PubMed - indexed for MEDLINE]


Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer.
Anticancer Res
Oh CR, DO JH, Oh HC, Choi YS, Lee SE, Hong SA, Hong M, Hwang IG.
PMID: 41895770 [PubMed - indexed for MEDLINE]


Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High-Risk Recurrence Factors: A Phase II Single-Center Prospective Study.
Cancer Med
Tian Y, Lei T, Ruan Q, Zhou X, Shen R, Xie T, Li S, Cai X, Chen M.
PMID: 41891390 [PubMed - indexed for MEDLINE]


Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study.
BJS Open
Al-Saffar HA, Ten Haaft BHEA, Marino R, De Bellis M, Olthof PB, Busund S, Schultz NA, Gilg S, Ruzzenente A, Groot Koerkamp B, Erdmann JI, Ratti F, Yaqub S, Pommergaard HC, Sturesson C.
PMID: 41871373 [PubMed - indexed for MEDLINE]


The evolving role of futibatinib for advanced cholangiocarcinoma.
Expert Rev Gastroenterol Hepatol
Persano M, Casadei-Gardini A, Camera S, Rimini M.
PMID: 41869869 [PubMed - indexed for MEDLINE]


Case Report: Spontaneous Tumor Lysis Syndrome in a Patient With Cholangiocarcinoma.
J Investig Med High Impact Case Rep
Lasprilla-Pallares MA, Nakazaki JC, Rivera-Castro JA.
PMID: 41867062 [PubMed - indexed for MEDLINE]


Treatment Outcomes of Durvalumab Combination Therapy in Patients with Biliary Tract Cancer.
Tokai J Exp Clin Med
Ito H, Kojima S, Tazawa Y, Omura Y, Yamaguchi T, Cho T, Yoshihara S, Nagata J, Hirose S, Ogasawara T, Izumi H, Kaneko J, Suzuki T.
PMID: 41859807 [PubMed - indexed for MEDLINE]


Lipidomic analysis of bile from patients with extrahepatic cholangiocarcinoma.
PLoS One
Choi SJ, Kim HJ, Kwon SW, Kim WS, Kim JS.
PMID: 41855188 [PubMed - indexed for MEDLINE]


Prophylactic Closure of Mucosal Defect to Prevent Delayed Bleeding After Endoscopic Papillectomy.
Can J Gastroenterol Hepatol
Dong J, Teng G, Zhang L, Niu H, Bian D, Feng Q.
PMID: 41846432 [PubMed - indexed for MEDLINE]


Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.
J Immunother Cancer
Ghiringhelli F, Kim R, Macarulla T, Moreno I, Abdul Razak A, Rodon Ahnert J, Liao CY, Davis SL, Mahipal A, Marron T, Raimbourg J, Kaplon H, Geronimi J, Harouki N, Rodrigues C, Darcel P, Jakobsen JS, Skartved N, Hald R, Lopez-Ravnborg D, He P, Ianopoulos X, Askoxylakis V, Lakhani N.
PMID: 41825935 [PubMed - indexed for MEDLINE]


Overcoming heterogeneity and immunosuppression: novel strategies in adoptive therapy for biliary tract cancer.
Front Immunol
Zhu Y, Xiong G, Guan M, Sun D, Guo Y, Peng J, Zhu H.
PMID: 41822509 [PubMed - indexed for MEDLINE]


A compass in the challenge: the CALLY index as a prognostic biomarker in advanced cholangiocarcinoma treated with chemoimmunotherapy: a retrospective propensity score-matched cohort study.
Front Immunol
Fan R, Lv Z, Wang T, Chen W, Han W, Mei Q.
PMID: 41816341 [PubMed - indexed for MEDLINE]


Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer: Implications for Biomarkers, Therapeutic Targeting, and Future Perspectives.
Cancer Control
Jaiswar D, Jeeyar V, Choudhury S, Dixit M.
PMID: 41804759 [PubMed - indexed for MEDLINE]


Gallbladder neuroendocrine carcinoma: a rare cause of ectopic ACTH secretion.
BMJ Case Rep
Tandon A, Mohanta BB, Rahul R, Dabadghao P.
PMID: 41802720 [PubMed - indexed for MEDLINE]


Epidemiology, biomarkers, and therapeutic approach in early-stage biliary tract cancers.
Chin Clin Oncol
Hung C, Kong J, Li A, Wu J.
PMID: 41797456 [PubMed - indexed for MEDLINE]


Radiological Loco-Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature.
Liver Int
Pallas D, Campani C, Sutter O, Nahon P, Ganne-Carrié N, Seror O, Nault JC.
PMID: 41797383 [PubMed - indexed for MEDLINE]


3Es-Based Program to Enhance Safety Behaviors Among Fermented Fish Producers in Northeast Thailand: Implications for Liver Fluke and Cholangiocarcinoma Prevention.
Asian Pac J Cancer Prev
Yokphochanachai C, Paengprakhon Y, Duangsri J, Songserm N.
PMID: 41793687 [PubMed - indexed for MEDLINE]


The Predictors of Liver Fluke Infection-Preventive Behaviors, Khon Kaen Province: A Structural Equation Model.
Asian Pac J Cancer Prev
Rattaporn W, Sillabutra J, Kitidamrongsuk P, Kamsa-Ard S, Satitvipawee P.
PMID: 41793671 [PubMed - indexed for MEDLINE]


Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.
N Engl J Med
Shi GM, Huang XY, Liang F, Liang X, Dong R, Ye QH, Gao Q, Ji Y, Yu ZP, Zhai WL, Lu JC, Li XW, Liu FB, Wang K, Yang W, Zhang JL, Hu ZQ, Qiu SJ, Wang XY, Yang XR, Sun HC, Shi YH, Ding ZB, Liu WR, Huang XW, Huang C, Shen YH, Sun J, He YF, Peng YF, Xu Y, Zou JJ, Zhou J, Fan J, ZSAB Study Group.
PMID: 41780001 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 17228    Seite 1 von 862  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1